Search For "glenmark"
Glenmark Pharma reports revenue growth of 13.9% and EBITDA growth of 30.8%
Updated : 4 years, 1 month ago IST
Mumbai (Maharashtra) [India], February 12 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a global innovation-driven pharmaceutical company, today announced its financial results for the third quarter ended December 31, 2021.
Read More
Glenmark launches Nitric Oxide Nasal Spray (FabiSpray®) in India for
Updated : 4 years, 1 month ago IST
Mumbai (Maharashtra) [India], February 9 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) - a global, innovation-driven pharmaceutical company and Canadian pharmaceutical company SaNOtize Research & Development Corp., today announced launch of its Nitric Oxide Nasal Spray un
Read More
First nasal spray for treating adult COVID-19 patients launched in India
Updated : 4 years, 1 month ago IST
New Delhi [India], February 9 (ANI): Mumbai based innovation-driven global pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India, in partnership with SaNOtize, for treatment of adult patients suffering from COVID-19.
Read More
Glenmark Specialty S.A. and Lotus International Pte. Ltd. enter into exclu
Updated : 4 years, 1 month ago IST
Mumbai (Maharashtra) [India], January 20 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global, integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Lot
Read More
Glenmark Pharmaceuticals receives ANDA tentative approval for Regadenoson
Updated : 4 years, 1 month ago IST
Mumbai (Maharashtra) [India], January 17 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc., USA (Glenmark) has received tentative approval by the United States Food & Drug Administration (U.S. FDA) for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single-Dose Pre-Filled Syringe, the g
Read More
Glenmark's subsidiary receives NDA Approval by US FDA for Ryaltris™
Updated : 4 years, 2 months ago IST
Mumbai (Maharashtra) [India], January 14 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company announced that its fully owned subsidiary Glenmark Specialty S.A. (Switzerland), received FDA approval on its New Drug Application (NDA) fo
Read More
Glenmark Pharmaceuticals makes it to the prestigious Dow Jones Sustainabil
Updated : 4 years, 4 months ago IST
Mumbai (Maharashtra) [India], November 16 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that the company has been listed in the Dow Jones Sustainability Index (DJSI), under the category of emerging markets
Read More
Glenmark Pharma reports revenue growth of 6.6% and PAT growth of 10.1% YoY
Updated : 4 years, 4 months ago IST
Mumbai (Maharashtra) [India], November 13 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, today announced its financial results for the second quarter ended Sept 30, 2021.
Read More
Glenmark becomes the first company to launch Remogliflozin + Vildagliptin
Updated : 4 years, 4 months ago IST
Mumbai (Maharashtra) [India], October 26 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed-dose combination (FDC) of its novel, patent-protected, globally researched Sodium-Glucose Co-Transporter Inhibitor (SGLT2i
Read More
Glenmark Pharmaceuticals launches fixed-drug combination for management of
Updated : 4 years, 4 months ago IST
Mumbai (Maharashtra) [India], October 26 (ANI): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed drug combination for the management of type 2 diabetes.
Read More
Glenmark launches Tavulus® for COPD treatment in Spain
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], October 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company today announced the launch of a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name Tavulus® in Spa
Read More
Glenmark receives marketing approval for Ryaltris®, an innovative com
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], September 30 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, has received marketing approval for its fixed-dose combination nasal spray Ryaltris® in 13 countries across the EU and UK.
Read More